T1	DEVI 34 43	emballage
#1	AnnotatorNotes T1	C0013194
T2	CHEM 56 71	Olanzapine Teva
#2	AnnotatorNotes T2	C0527258
T3	CHEM 80 100	comprimés pelliculés
#3	AnnotatorNotes T3	C1273643
T4	CHEM 80 89	comprimés
#4	AnnotatorNotes T4	C0039225
T5	CHEM 110 128	comprimé pelliculé
#5	AnnotatorNotes T5	C1273643
T6	CHEM 110 118	comprimé
#6	AnnotatorNotes T6	C0039225
T7	CHEM 152 159	lactose
#7	AnnotatorNotes T7	C0022949
T8	CHEM 164 172	Comprimé
#8	AnnotatorNotes T8	C0039225
T9	LIVB 254 261	Enfants
#9	AnnotatorNotes T9	C0008059
T10	LIVB 265 276	adolescents
#10	AnnotatorNotes T10	C0205653
T11	CHEM 300 310	olanzapine
#11	AnnotatorNotes T11	C0171023
T12	LIVB 320 327	enfants
#12	AnnotatorNotes T12	C0008059
T13	LIVB 335 346	adolescents
#13	AnnotatorNotes T13	C0205653
T14	PROC 383 394	recommandée
#14	AnnotatorNotes T14	C1136220
T15	PHEN 431 439	sécurité
#15	AnnotatorNotes T15	C0036043
T16	DISO 492 524	Affections musculo-squelettiques
#16	AnnotatorNotes T16	C0263660
T17	DISO 492 502;543 551	Affections osseuses
#17	AnnotatorNotes T17	C0005940
T18	ANAT 543 551	osseuses
#18	AnnotatorNotes T18	C0005931
T19	DISO 552 565	Rhabdomyolyse
#19	AnnotatorNotes T19	C0035410
T20	DISO 566 584	Affections du rein
#20	AnnotatorNotes T20	C0022658
T21	ANAT 580 584	rein
#21	AnnotatorNotes T21	C0022646
T22	DISO 566 576;588 607	Affections des voies urinaires
#22	AnnotatorNotes T22	C0042075
T23	ANAT 592 607	voies urinaires
#23	AnnotatorNotes T23	C0042027
T24	DISO 608 615	Dysurie
#24	AnnotatorNotes T24	C0013428
T25	PHYS 642 654	reproduction
#25	AnnotatorNotes T25	C0035150
T26	DISO 616 626;658 665	Affections du sein
#26	AnnotatorNotes T26	C00061145
T27	ANAT 661 665	sein
#27	AnnotatorNotes T27	C0006141
T28	DISO 666 675	Priapisme
#28	AnnotatorNotes T28	C0033117
T29	LIVB 761 786	populations particulières
#29	AnnotatorNotes T29	C0242444
T30	PROC 800 816	essais cliniques
#30	AnnotatorNotes T30	C2603343
T31	LIVB 826 839	patients âgés
#31	AnnotatorNotes T31	C0001792
T32	LIVB 826 834	patients
#32	AnnotatorNotes T32	C0030705
T33	DISO 840 847	déments
#33	AnnotatorNotes T33	C0860630
T34	PROC 853 863	traitement
#34	AnnotatorNotes T34	C0087111
T35	CHEM 868 878	olanzapine
#35	AnnotatorNotes T35	C0171023
T36	PHYS 923 928	décès
#36	AnnotatorNotes T36	C0011065
T37	DISO 936 959	événements indésirables
#37	AnnotatorNotes T37	C0559546
T38	ANAT 960 971	vasculaires
#38	AnnotatorNotes T38	C0005847
T39	ANAT 972 981	cérébraux
#39	AnnotatorNotes T39	C0006104
T40	CHEM 997 1004	placebo
#40	AnnotatorNotes T40	C1696465
T41	CHEM 1032 1044	Hypromellose
#41	AnnotatorNotes T41	C0063242
T42	CHEM 1073 1085	polydextrose
#42	AnnotatorNotes T42	C0071545
T43	CHEM 1088 1100	hypromellose
#43	AnnotatorNotes T43	C0063242
T44	CHEM 1103 1112	diacétate
#44	AnnotatorNotes T44	C0369114
T45	CHEM 1116 1124	glycérol
#45	AnnotatorNotes T45	C0017861
T46	CHEM 1143 1160	dioxyde de titane
#46	AnnotatorNotes T46	C0076733
T47	CHEM 1143 1150	dioxyde
#47	AnnotatorNotes T47	C0678717
T48	CHEM 1154 1160	titane
#48	AnnotatorNotes T48	C0040302
T49	CHEM 1161 1165	E171
#49	AnnotatorNotes T49	C3256964
T50	CHEM 1168 1186	oxyde de fer rouge
#50	AnnotatorNotes T50	C3256884
T51	CHEM 1168 1180	oxyde de fer
#51	AnnotatorNotes T51	C0060240
T52	CHEM 1168 1173	oxyde
#52	AnnotatorNotes T52	C0030015
T53	CHEM 1177 1180	fer
#53	AnnotatorNotes T53	C0302583
T54	CHEM 1196 1211	Olanzapine Teva
#54	AnnotatorNotes T54	C0527258
T55	CHEM 1219 1244	comprimés orodispersibles
#55	AnnotatorNotes T55	C2960508
T56	CHEM 1219 1228	comprimés
#56	AnnotatorNotes T56	C0039225
T57	CHEM 1254 1277	comprimé orodispersible
#57	AnnotatorNotes T57	C2960508
T58	CHEM 1254 1262	comprimé
#58	AnnotatorNotes T58	C0039225
T59	CHEM 1296 1306	olanzapine
#59	AnnotatorNotes T59	C0171023
T60	CHEM 1318 1341	comprimé orodispersible
#60	AnnotatorNotes T60	C2960508
T61	CHEM 1318 1326	comprimé
#61	AnnotatorNotes T61	C0039225
T62	CHEM 1371 1381	tartrazine
#62	AnnotatorNotes T62	C0039329
T63	OBJC 1382 1387	laque
#63	AnnotatorNotes T63	C0022902
T64	CHEM 1407 1430	comprimé orodispersible
#64	AnnotatorNotes T64	C2960508
T65	CHEM 1407 1415	comprimé
#65	AnnotatorNotes T65	C0039225
T66	CHEM 1462 1475	Comprimé rond
#66	AnnotatorNotes T66	C0994475
T67	CHEM 1462 1470	Comprimé
#67	AnnotatorNotes T67	C0039225
T68	PHEN 1484 1491	couleur
#68	AnnotatorNotes T68	C0009393
T69	PROC 1557 1564	retirer
#69	AnnotatorNotes T69	C0015252
T70	CHEM 1575 1598	comprimé orodispersible
#70	AnnotatorNotes T70	C2960508
T71	CHEM 1575 1583	comprimé
#71	AnnotatorNotes T71	C0039225
T72	CHEM 1606 1629	comprimé orodispersible
#72	AnnotatorNotes T72	C2960508
T73	CHEM 1606 1614	comprimé
#73	AnnotatorNotes T73	C0039225
T74	PROC 1659 1669	administré
#74	AnnotatorNotes T74	C1533734
T75	CHEM 1706 1728	plaquette thermoformée
#75	AnnotatorNotes T75	C1319688
T76	PROC 1756 1763	dissous
#76	AnnotatorNotes T76	C1285147
T77	DEVI 1778 1783	verre
#77	AnnotatorNotes T77	C1947936
T78	CHEM 1788 1791	eau
#78	AnnotatorNotes T78	C0043047
T79	OBJC 1812 1819	boisson
#79	AnnotatorNotes T79	C0524819
T80	OBJC 1830 1844	jus d ’ orange
#80	AnnotatorNotes T80	C0452458
T81	OBJC 1830 1833	jus
#81	AnnotatorNotes T81	C1268568
T82	OBJC 1838 1844	orange
#82	AnnotatorNotes T82	C0440277
T83	OBJC 1847 1859	jus de pomme
#83	AnnotatorNotes T83	C0452454
T84	OBJC 1847 1850	jus
#84	AnnotatorNotes T84	C1268568
T85	OBJC 1854 1859	pomme
#85	AnnotatorNotes T85	C1095830
T86	OBJC 1862 1866	lait
#86	AnnotatorNotes T86	C0349374
T87	OBJC 1870 1874	café
#87	AnnotatorNotes T87	C0009237
T88	PROC 1897 1911	administration
#88	AnnotatorNotes T88	C1533734
T89	CHEM 1920 1930	olanzapine
#89	AnnotatorNotes T89	C0171023
T90	CHEM 1931 1954	comprimé orodispersible
#90	AnnotatorNotes T90	C2960508
T91	CHEM 1931 1939	comprimé
#91	AnnotatorNotes T91	C0039225
T92	CHEM 2006 2021	comprimé enrobé
#92	AnnotatorNotes T92	C1273642
T93	CHEM 2006 2014	comprimé
#93	AnnotatorNotes T93	C0039225
T94	CHEM 2111 2126	Olanzapine Teva
#94	AnnotatorNotes T94	C0527258
T95	CHEM 2129 2149	comprimés pelliculés
#95	AnnotatorNotes T95	C1273643
T96	CHEM 2129 2138	comprimés
#96	AnnotatorNotes T96	C0039225
T97	CHEM 2213 2229	antipsychotiques
#97	AnnotatorNotes T97	C0040615
T98	PROC 2239 2249	recommandé
#98	AnnotatorNotes T98	C1136220
T99	PHYS 2279 2298	pression artérielle
#99	AnnotatorNotes T99	C0871470
T100	ANAT 2288 2298	artérielle
#100	AnnotatorNotes T100	C0003842
T101	LIVB 2303 2329	patients de plus de 65 ans
#101	AnnotatorNotes T101	C0001792
T102	LIVB 2303 2311	patients
#102	AnnotatorNotes T102	C0030705
T103	CHEM 2338 2347	comprimés
#103	AnnotatorNotes T103	C0039225
T104	CHEM 2408 2430	plaquette thermoformée
#104	AnnotatorNotes T104	C1319688
T105	OBJC 2438 2442	film
#105	AnnotatorNotes T105	C1561572
T106	CHEM 2457 2466	plaquette
#106	AnnotatorNotes T106	C1319688
T107	PROC 2477 2484	retirée
#107	AnnotatorNotes T107	C0015252
T108	CHEM 2500 2508	comprimé
#108	AnnotatorNotes T108	C0039225
T109	LIVB 2517 2525	patients
#109	AnnotatorNotes T109	C0030705
T110	DISO 2539 2560	troubles héréditaires
#110	AnnotatorNotes T110	C0019247
T111	DISO 2570 2604	malabsorption du glucose-galactose
#111	AnnotatorNotes T111	C0865194
T112	DISO 2570 2583	malabsorption
#112	AnnotatorNotes T112	C0024523
T113	CHEM 2631 2641	médicament
#113	AnnotatorNotes T113	C0013227
T114	ANAT 2664 2676	plasmatiques
#114	AnnotatorNotes T114	C0032105
T115	CHEM 2680 2689	valproate
#115	AnnotatorNotes T115	C0080356
T116	CHEM 2748 2757	valproate
#116	AnnotatorNotes T116	C0080356
T117	PROC 2788 2798	traitement
#117	AnnotatorNotes T117	C0087111
T118	CHEM 2807 2817	olanzapine
#118	AnnotatorNotes T118	C0171023
T119	DISO 2842 2874	Affections musculo-squelettiques
#119	AnnotatorNotes T119	C0263660
T120	DISO 2842 2852;2893 2901	Affections osseuses
#120	AnnotatorNotes T120	C0005940
T121	ANAT 2893 2901	osseuses
#121	AnnotatorNotes T121	C0005931
T122	DISO 2902 2915	Rhabdomyolyse
#122	AnnotatorNotes T122	C0035410
T123	DISO 2916 2934	Affections du rein
#123	AnnotatorNotes T123	C0022658
T124	ANAT 2930 2934	rein
#124	AnnotatorNotes T124	C0022646
T125	DISO 2916 2926;2938 2957	Affections des voies urinaires
#125	AnnotatorNotes T125	C0042075
T126	ANAT 2942 2957	voies urinaires
#126	AnnotatorNotes T126	C0042027
T127	DISO 2958 2965	Dysurie
#127	AnnotatorNotes T127	C0013428
T128	PHYS 2992 3004	reproduction
#128	AnnotatorNotes T128	C0035150
T129	DISO 2966 2976;3008 3015	Affections du sein
#129	AnnotatorNotes T129	C00061145
T130	ANAT 3011 3015	sein
#130	AnnotatorNotes T130	C0006141
T131	DISO 3016 3025	Priapisme
#131	AnnotatorNotes T131	C0033117
T132	LIVB 3111 3136	populations particulières
#132	AnnotatorNotes T132	C0242444
T133	PROC 3150 3166	essais cliniques
#133	AnnotatorNotes T133	C2603343
T134	LIVB 3176 3189	patients âgés
#134	AnnotatorNotes T134	C0001792
T135	LIVB 3176 3184	patients
#135	AnnotatorNotes T135	C0030705
T136	DISO 3190 3197	déments
#136	AnnotatorNotes T136	C0860630
T137	PROC 3203 3213	traitement
#137	AnnotatorNotes T137	C0087111
T138	CHEM 3218 3228	olanzapine
#138	AnnotatorNotes T138	C0171023
T139	PHYS 3273 3278	décès
#139	AnnotatorNotes T139	C0011065
T140	DISO 3286 3309	événements indésirables
#140	AnnotatorNotes T140	C0559546
T141	ANAT 3310 3321	vasculaires
#141	AnnotatorNotes T141	C0005847
T142	ANAT 3322 3331	cérébraux
#142	AnnotatorNotes T142	C0006104
T143	CHEM 3347 3354	placebo
#143	AnnotatorNotes T143	C1696465
T144	PROC 3391 3410	études précliniques
#144	AnnotatorNotes T144	C1709631
T145	PROC 3391 3397	études
#145	AnnotatorNotes T145	C2603343
T146	CHEM 3417 3427	olanzapine
#146	AnnotatorNotes T146	C0171023
T147	CHEM 3464 3474	récepteurs
#147	AnnotatorNotes T147	C0597357
T148	PROC 3491 3496	étude
#148	AnnotatorNotes T148	C2603343
T149	PROC 3500 3536	tomographie par émission de positron
#149	AnnotatorNotes T149	C0032743
T150	PROC 3500 3511	tomographie
#150	AnnotatorNotes T150	C0040395
T151	PROC 3539 3542	PET
#151	AnnotatorNotes T151	C0032743
T152	LIVB 3553 3563	volontaire
#152	AnnotatorNotes T152	C1997894
T153	CHEM 3616 3626	olanzapine
#153	AnnotatorNotes T153	C0171023
T154	CHEM 3657 3667	récepteurs
#154	AnnotatorNotes T154	C0597357
T155	CHEM 3697 3707	récepteurs
#155	AnnotatorNotes T155	C0597357
T156	DISO 3719 3730	neutropénie
#156	AnnotatorNotes T156	C0027947
T157	DISO 3748 3764	thrombocytopénie
#157	AnnotatorNotes T157	C0040034
T158	DISO 3785 3791	anémie
#158	AnnotatorNotes T158	C0002871
T159	LIVB 3821 3827	chiens
#159	AnnotatorNotes T159	C0012984
T160	PROC 3828 3835	traités
#160	AnnotatorNotes T160	C0087111
T161	DISO 3866 3876	exposition
#161	AnnotatorNotes T161	C2905623
T162	CHEM 3890 3900	olanzapine
#162	AnnotatorNotes T162	C0171023
T163	LIVB 3973 3978	homme
#163	AnnotatorNotes T163	C0086418
T164	CHEM 4013 4021	Mannitol
#164	AnnotatorNotes T164	C0024730
T165	CHEM 4024 4028	E421
#165	AnnotatorNotes T165	C0024730
T166	CHEM 4031 4061	Glycolate d ’ amidon de sodium
#166	AnnotatorNotes T166	C0142927
T167	CHEM 4031 4040	Glycolate
#167	AnnotatorNotes T167	C0017948
T168	CHEM 4045 4061	amidon de sodium
#168	AnnotatorNotes T168	C3256938
T169	CHEM 4045 4051	amidon
#169	AnnotatorNotes T169	C0038179
T170	CHEM 4055 4061	sodium
#170	AnnotatorNotes T170	C0037473
T171	OBJC 4083 4088	Arôme
#171	AnnotatorNotes T171	C0475332
T172	LIVB 4089 4096	vanille
#172	AnnotatorNotes T172	C1015855
T173	CHEM 4097 4107	Tartrazine
#173	AnnotatorNotes T173	C0039329
T174	OBJC 4108 4113	laque
#174	AnnotatorNotes T174	C0022902
T175	CHEM 3657 3673	récepteurs 5HT2A
#175	AnnotatorNotes T175	C0289174
T176	CHEM 3697 3710	récepteurs D2
#176	AnnotatorNotes T176	C0058698
T177	DISO 492 502;528 539	Affections systémiques
#177	AnnotatorNotes T177	C0442893
T178	DISO 2842 2852;2878 2889	Affections systémiques
#178	AnnotatorNotes T178	C0442893
T179	DISO 616 654	Affections des organes de reproduction
#179	AnnotatorNotes T179	C0178829
T180	DISO 2966 3004	Affections des organes de reproduction
#180	AnnotatorNotes T180	C0178829
